Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan ADC Therapeutics SA (ADCT)

adctherapeutics.com (ADCT) - logo korporat

The slow clinical adoption of Zynlonta and equity dilution are weighing on the finances of ADC Therapeutics (ADCT). The current level of quarterly EPS growth illustrates this trend, where the 45.70 mark serves as a critical threshold. Outsourced manufacturing ensures supply stability, while the development of targeted therapy relies on highly compensated scientists and generous stock option programs.

adctherapeutics.com (ADCT) - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan saka 04.07.2022 nganti 16.11.2026

Rincian metrik komprehensif lan analitis ADC Therapeutics (ADCT)

- nilai pasar lan prakiraan target analis:
Analisis dhasar perusahaan:ADC Therapeutics Corp, ADCT
Barang unggulan ADC Pharma

Quarterly EPS growth measures the percentage change in net income per share compared to the same period last year. This metric allows for an assessment of capital management efficiency and business scaling rates. The quarterly EPS trend captured on GURU.Markets visualizes the cyclicality of the issuer's returns. For ADC Therapeutics (ADCT), this indicator reflects the financial success of the commercialization of the drug ZYNLONTA. A positive trend confirms the growing market share of targeted oncology therapy.

Karo sapa ADC Therapeutics saingan

tgtherapeutics.com (TGTX) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Arcellx Therapeutics (ACLX)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Disc Medicine Inc|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Syndax Pharmaceuticals SNDX|Wutah bathi EPS kuartalan KURA|Foghorn Therapeutics Inc. - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan vorbio.com VOR|NKTX: Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|COEP - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Actinium Pharmaceuticals, Inc. (ATNM) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|ESLA (Estrella Immunopharma) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|CASI - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Marker Bio|Wutah bathi EPS kuartalan IN8bio, Inc.|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Eterna Therapeutics Inc (ERNA)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan gtbiopharma.com|Wutah bathi EPS kuartalan APTO (Aptose Biosciences)|Wutah bathi EPS kuartalan Bio-Path BPTH|MEI Pharma Inc - Wutah bathi EPS kuartalan|VINC (Vincerx Pharma Inc.) - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan